Current management and future perspectives of penile cancer: an updated review

Penile cancer (PeCa) represents a rare disease worldwide, accounting for less than one percent of all malignancies in men [1] with devastating physical and psychological effects. Although PeCa may affect young males, it is most commonly diagnosed in the sixth and seventh decade of life [2]. While PeCa is uncommon in developed countries, it remains a significant public health concern in developing nations with an alarming higher incidence in some areas [3,4].
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Source Type: research